Petco Stock Just Surged 52% In a Week. Should You Buy In?

Petco swung to a $9.1M net profit in fiscal 2025 from a $101.8M net loss, operating cash flow rose 77% to $314.1M, and the stock surged 34.6% in one session (up >52% over the week). The company paid down $95M of debt, finished the year with $256.7M in cash (+$91M y/y), cut inventory 9.7%, expanded gross margin 66 bps to 38.7% and improved leverage from 4.2x to 3.0x after refinancing to 2031, but still carries about $1.5B of long-term debt with interest coverage near 1x and comps remain negative (Q4 comps -1.6%). Management guides fiscal 2026 sales flat to +1.5% and adj. EBITDA of $415–$430M; margin progress and a 1,382-store service hub footprint support a positive long-term case, yet near-term caution is warranted until comps turn positive.

Analysis

Petco's pivot toward services converts real estate from a distribution liability into a recurring-revenue asset; if management can raise per-store utilization by 10-15% over 12-18 months, incremental margins on services will dwarf incremental retail margins and materially lift consolidated ROIC. That dynamic tightens the competitive moat versus e-commerce-only players, but it also concentrates execution risk in hiring, scheduling and local marketing — areas where unit economics can swing wildly quarter-to-quarter.

Credit sensitivity is the underappreciated margin lever. With elevated leverage, the company’s equity is banked on a small number of positive comp prints and sustained gross-margin expansion; an adverse macro shock or slower-than-expected comp recovery can compress interest coverage rapidly and force refinancing at a higher cost. Conversely, the refinancing runway buys time for the services rollout, so the next 2-4 quarters of comparable-store sales are the true binary catalyst for valuation re-rating.

Second-order winners include regional vet service operators, grooming franchise consolidators and premium fresh-food suppliers that gain negotiating power as Petco scales proprietary SKUs; national CPG brands face tougher shelf negotiations and margin pressure in private-label-heavy assortments. Chewy’s playbook risks margin compression if it pursues services via third-party clinics — customer LTV gains from in-person services are stickier and harder for pure-play e-comm to replicate without heavy capex and customer acquisition resets.

Given the above, the stock is not a binary buy on the earnings print alone — it’s a conditional trade tied to execution across operations, comps and the credit market. Watch monthly comp trends, gross-margin cadence, service revenue mix and any incremental capital allocated to vet/clinic rollouts as the high-frequency indicators that will drive relative performance over the next 3–12 months.

Key Decisions for Investors

• Initiate a tactical pair: Long WOOF / Short CHWY (dollar-neutral) with a 3–12 month horizon. Rationale: capture services moat re-rating vs e-comm margin pressure. Risk control: 10% stop on either leg; target 30–40% relative outperformance.
• Buy WOOF 12–18 month LEAPS calls slightly OTM (delta ~0.35) sized as 2–4% of long book to express asymmetric upside if comps inflect. Hedge by selling near-term (3-month) calls to fund ~25–35% of premium. Timeframe: hold through two comp prints; roll/exit if EBITDA guidance misses by >5%.
• Short-term hedge: Buy a 3–6 month WOOF put spread (OTM protection) sized to cover downside from a negative comp surprise or credit reprice. Cost-effective protection if leverage-sensitive risks materialize over the next 6 months.
• Event-driven credit play: Monitor corporate bond curves — if spreads widen >75bp vs peers on a weak comp print, consider buying the bonds (or reducing equity) to capture yield while recovery is plausible post-refinancing. Timeframe: 6–24 months; downside: restructuring risk if cash flow deteriorates further.